drugset / Trial / NCT00057122

Tuberculosis Prevention for HIV Infected Adults

NCT00057122

RandomizedParallel-groupOpen-labelPrevention

Summary

This study compares three different tuberculosis (TB) prevention regimens against the standard regimen of 6 months of isoniazid. It is being conducted in Soweto, South Africa. People who are HIV positive and have a positive tuberculin skin test without signs of active tuberculosis may join.

Timeline

Start
2002-09
Primary completion
2008-11
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Isoniazid Small molecule 300 mg
Comparator Isoniazid Small molecule 900 mg
Comparator Rifampin Small molecule 600 mg
Comparator Rifapentine Small molecule 900 mg